Aspen Group, Inc.

ASPU • Education & Training Services

$0.27

▲ +0.02 (+8.97%)

Precio actual

ResultadosÚltimo reporte: 30 abr 2026

PERFIL DE MAYOR RIESGOPrecauciónConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Conviene actuar con cautela. Los ratios recientes muestran debilidades que pueden limitar el retorno si los fundamentales no mejoran.

Capitalización

$8.12M

Crecimiento

—

Flujo de caja

2/5

Tendencia

Volatile

Evidencia

Flujo de caja libre positivo · 0.08Nivel de deuda manejable · 0.61Liquidez débil · 0.95Rentabilidad débil

Datos financieros hasta: 30 abr 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 abr 2026, 12:00 a.m. UTCÚltima actualización del perfil: 20 ago 2026, 12:20 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$0.27

Change8.97%

Shares Out30.09M

Market Cap$8.12M

Enterprise Value$15.43M

52W Range0.04 - 0.41

Beta-0.84

P/E-4.42

P/S0.19

P/B0.28

P/FCF3.62

EV/Sales0.36

Price$0.27

Change8.97%

Shares Out30.09M

Market Cap$8.12M

Enterprise Value$15.43M

52W Range0.04 - 0.41

Beta-0.84

P/E-4.42

P/S0.19

P/B0.28

P/FCF3.62

EV/Sales0.36

EV/EBITDA3.07

EV/FCF6.88

Earnings Yield-22.63%

FCF Yield27.64%

Dividend Yield0.00%

Gross Margin72.63%

Oper. Margin5.81%

Profit Margin-4.24%

Debt/Eq0.61

Current Ratio0.95

Quick Ratio0.95

Target$3.00

Target Upside1012.35%

Target Median$3.00

Target Range3.00 - 3.00

Volume137.93K

Avg Volume38.62K

EPS Surprise-0.06

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

23/100

Fortaleza financiera

Deuda, caja, estabilidad

51/100

Potencial de crecimiento

Ingresos y expansión

58/100

Atractivo del precio

Barata o cara hoy

95/100

Por qué este puntaje▼

Flujo de caja libre positivo · 0.08Nivel de deuda manejable · 0.61Liquidez débil · 0.95Rentabilidad débil

Analyst view

Analyst sentiment and price target

ASPU

Analyst sentiment

Based on 6 analyst votes · 2026-09-05

67/100

Neutral

Bullish

Hold

Bearish

Precio objetivo

2026-08-20

Bajo

$3.00

Promedio

$3.00

Mediana

$3.00

Alto

$3.00

Resumen de la compañía

IPO: 3/29/2012

Industria: Education & Training Services

P/B i: 0.28

Deuda / Patrimonio i: 0.61

Margen operativo: 5.81%

Margen neto: -4.24%

ROE i: -

ROIC: -

Salud financiera

Puntaje10 / 20

Deuda / Patrimonio: 0.61

Ratio corriente: 0.95

Ratio rápido: 0.95

Estado: Moderate

Advertencias

Weak Liquidity

Transacciones internas

Actividad reciente de ejecutivos e insiders

Koehneman Michael L

Transacción: 10/03/2023

COMPRA

Cambio

+10,000

Precio

$0.18

Presentación

10/04/2023

Tipo

COMPRA

Koehneman Michael L

Transacción: 10/02/2023

COMPRA

Cambio

+5,623

Precio

$0.17

Presentación

10/04/2023

Tipo

COMPRA

KASS DOUGLAS

Transacción: 09/29/2023

COMPRA

Cambio

+25,000

Precio

$0.18

Presentación

10/02/2023

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Koehneman Michael L	COMPRA	+10,000	$0.18	10/03/2023	10/04/2023
Koehneman Michael L	COMPRA	+5,623	$0.17	10/02/2023	10/04/2023
KASS DOUGLAS	COMPRA	+25,000	$0.18	09/29/2023	10/02/2023
KASS DOUGLAS	COMPRA	+14,500	$0.18	09/28/2023	09/29/2023
KASS DOUGLAS	COMPRA	+500	$0.18	09/27/2023	09/28/2023
KASS DOUGLAS	COMPRA	+15,000	$0.17	09/26/2023	09/27/2023
KASS DOUGLAS	COMPRA	+32,500	$0.18	09/25/2023	09/27/2023
KASS DOUGLAS	COMPRA	+22,500	$0.16	09/20/2023	09/21/2023
KASS DOUGLAS	COMPRA	+25,000	$0.15	09/19/2023	09/20/2023
KASS DOUGLAS	COMPRA	+50,000	$0.14	09/18/2023	09/20/2023
LaVay Matthew	COMPRA	+500,000	Not reported	08/29/2023	08/30/2023
Mathews Michael	COMPRA	+15,157	Not reported	07/08/2023	07/11/2023
Arnauld Cheri St.	COMPRA	+13,991	Not reported	07/08/2023	07/11/2023
KASS DOUGLAS	COMPRA	+4,750	$0.32	01/03/2023	01/04/2023
KASS DOUGLAS	COMPRA	+10,250	$0.28	12/30/2022	01/03/2023
KASS DOUGLAS	COMPRA	+5,000	$0.28	12/29/2022	01/03/2023
KASS DOUGLAS	COMPRA	+7,000	$0.27	12/28/2022	12/29/2022
KASS DOUGLAS	COMPRA	+33,000	$0.27	12/27/2022	12/29/2022
KASS DOUGLAS	COMPRA	+15,500	$0.34	09/27/2022	09/28/2022
KASS DOUGLAS	COMPRA	+11,500	$0.39	09/26/2022	09/27/2022

Sobre la compañía

Aspen Group, Inc.

Aspen Group, Inc. functions as an education technology enterprise, concentrating on providing virtual higher education offerings throughout the United States. The company delivers an extensive array of academic qualifications, encompassing undergraduate, graduate, and doctoral degrees. These programs cover diverse fields such as nursing and health sciences, business and technology, liberal arts and sciences, and pedagogical studies. All these educational pathways are accessible through its two affiliated institutions: Aspen University and United States University. Founded in 1987, Aspen Group, Inc. had a student population of 13,334 individuals actively pursuing degrees as of April 30, 2022. The firm maintains its operational base in New York, New York.

Fuente - Link

Competidores

APRU BABYF BRWC CYAN HRSR IFBC LTRE QOEG RSAU YWGRF

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

AM Best Removes From Under Review With Positive Implications and Upgrades Credit Ratings of Aspen Insurance Holdings Limited and its Rated Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has removed from under review with positive implications and upgraded the Financial Strength Rating (FSR) to A+ (Superior) from A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) to “aa-” (Superior) from “a” (Excellent) of Aspen Insurance UK Limited (AIUK) (United Kingdom), Aspen Bermuda Limited (ABL) (Bermuda), Aspen American Insurance Company (AAIC) (Texas) and Aspen Specialty Insurance Company (ASIC) (North Dakota). The outlook assig.

Business Wire

Aspen sees Mounjaro Africa sales above $124 million in 2027

Aspen Pharmacare expects African sales ‌of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in its current financial year, buoyed by surging demand in South Africa and planned launches in Nigeria and Kenya.

Reuters

Aspen Group Reports Fourth Quarter and Fiscal Year 2026 Results

United States University revenue increased 5% during Fiscal 2026, driven by solid organic lead generation Generated operating cash flow of $1.0 million in the fourth quarter, up from $0.6 million, enabling the resumption of marketing spend Gross margin expanded by 533 bps to 76% in the fourth quarter, lifting full year gross margin to 75% Fourth quarter net loss of $(4.3) million reflects two non-recurring non-cash charges totaling $3.2 million; Fiscal 2026 net loss was $(1.8) million Record fourth quarter Adjusted EBITDA of $3.3 million, up from $2.0 million; Fiscal 2026 Adjusted EBITDA reaches $10.6 million, a Company record, up from $5.7 million PHOENIX, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (OTCQB: ASPU) (“AGI” or the “Company”), an education technology holding company, today announced financial results for its fourth quarter of fiscal year 2026, ended April 30, 2026. Fourth Quarter Fiscal Year 2026 Summary Results Three Months Ended April 30, Years Ended April 30, $ in millions, except per share data 2026 2025 2026 2025 Revenue $ 10.3 $ 11.6 $ 43.3 $ 45.3 Gross Profit1 $ 7.8 $ 8.2 $ 32.5 $ 31.3 Gross Margin (%)1 76 % 71 % 75 % 69 % Net Income (Loss)2 $ (4.3 ) $ 0.6 $ (1.8 ) $ (1.5 ) Earnings (Loss) per Share - Basic $ (0.14 ) $ 0.02 $ (0.07 ) $ (0.07 ) Earnings (Loss) per Share - Diluted $ (0.14 ) $ 0.01 $ (0.07 ) $ (0.07 ) EBITDA3 $ (3.5 ) $ 1.7 $ 1.9 $ 2.9 Adjusted EBITDA3 $ 3.3 $ 2.0 $ 10.6 $ 5.7 _______________________ 1 GAAP gross profit calculation includes marketing, promotional and instructional costs, and amortization expense of $0.3 million and $0.4 million, and $1.5 million and $1.8 million, respectively for the three and twelve months ended April 30, 2026 and 2025, respectively.

GlobeNewsWire

Aspen Aerogels: Green Shoots Fail To Truly Impress Investors

Aspen Aerogels delivered sequential revenue and EBITDA improvement, with Q2 revenues topping guidance and Q3 outlook signaling further recovery. Thermal Barrier sales rebounded sequentially, especially in Europe, but remain pressured by regulatory shifts and evolving battery technologies. ASPN's EBITDA break-even threshold lowered to $175 million in annual revenue, reflecting cost discipline and operational progress despite fire-related disruptions.

Seeking Alpha

Aspen Aerogels Reminds Us Materials Science Can Be Cool, Especially If EVs Are Hot

Consider the kinds of endeavors that capture our interest. My theory: They often relate to things we can see, understand and admire in day to day life. This is probably why more children aspire to be actors than, say, accountants, and why investors gravitate more to AI or fancy tech, than say, materials science.

Seeking Alpha

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2024-05-02	-0.09	-0.15	-0.06
2024-01-18	-0.07	-0.06	0.01
2023-05-16	-0.08	-0.06	0.02
2023-05-01	-0.06	-0.06127	-0.00127
2022-12-13	-0.06667	-0.07	-0.00333
2022-09-13	-0.11	-0.13	-0.02
2022-07-19	-0.1075	-0.05	0.0575
2022-03-15	-0.09	-0.12	-0.03
2021-12-14	-0.04	-0.08	-0.04
2021-09-14	-0.05	-0.03	0.02
2021-07-13	-0.05	-0.04	0.01
2021-03-16	-0.04167	-0.09	-0.04833